naringenin has been researched along with Hormone-Dependent Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acconcia, F; Bolli, A; Bulzomi, P; Galluzzo, P; Leone, S; Marino, M | 1 |
| Chen, I; Connor, K; Howell, J; Ruh, MF; Safe, S; Zacharewski, T | 1 |
2 other study(ies) available for naringenin and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Naringenin and 17beta-estradiol coadministration prevents hormone-induced human cancer cell growth.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Estradiol; Estrogen Antagonists; Flavanones; HeLa Cells; Hep G2 Cells; Humans; Neoplasms, Hormone-Dependent; Promoter Regions, Genetic; Signal Transduction | 2010 |
Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
Topics: Animals; Base Sequence; Breast Neoplasms; Cytosol; Electrophoresis; Estradiol; Estrogen Antagonists; Female; Flavanones; Flavonoids; Humans; Molecular Sequence Data; Neoplasms, Hormone-Dependent; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured; Uterus | 1995 |